Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Frontiers in Clinical Drug Research - Diabetes and Obesity; Volume 2
Type
Physical Book
Language
Inglés
Pages
248
Format
Paperback
Dimensions
25.4 x 17.8 x 1.6 cm
Weight
0.60 kg.
ISBN13
9781681081861

Frontiers in Clinical Drug Research - Diabetes and Obesity; Volume 2

Ur-Rahman, Atta (Author) · Bentham Science Publishers · Paperback

Frontiers in Clinical Drug Research - Diabetes and Obesity; Volume 2 - Ur-Rahman, Atta

New Book

£ 105.68

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Thursday, July 11 and Thursday, July 18.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Frontiers in Clinical Drug Research - Diabetes and Obesity; Volume 2"

Frontiers in Clinical Drug Research - Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research. The second volume of this series features 7 reviews presenting updates on hormones and several classes of drugs: - Osteocalcin action in glucose metabolism - Sodium-glucose co-transporter 2 (SGLT2) inhibitors - Glucagon-like peptide-1 (GLP-1) mimetics - Dipeptidyl peptidase 4 (DPP-4) inhibitors - New drugs in clinical trial and commercial phases

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews